Location: Home
  • search
  • go
  • Relate News
  • 8/21/2018Upcoming Event: Shanghai eHealth Workshop
  • 8/17/2018CDE Solicits Comments of Draft Guidelines for Aluminum Adjuvant in Pre...
  • 8/16/2018Top Drug Regulators and Senior Local Officials Punished over Vaccine S...
  • 8/14/2018India's Pharmexcil to sign MoU with China Trade Body for Expedite Drug...
  • 8/9/2018Pfizer's Breast Cancer Drug Ibrance Receives Approval in China
  • 8/7/2018NHC Investigating A New Vaccine Case Involving Expired Vaccines in Sha...
  • 8/6/2018China-related Drug Scandals Showcase Risks in Global Supply Chains
  • 7/31/2018Shandong CDC Official Attempts Suicide in the Wake of Vaccine Scandal
  • 7/31/2018How China's Protectionist Vaccine Policy Has Backfired on Beijing
  • 7/31/2018A Solution to China's Pharma Woes Might Be a Blockchain Away
  • 7/27/2018Bio-Thera Initiates Phase I Trial for Biosimilar of Actemra (Tocilizum...
  • 7/24/2018Senior Executives of Scandalous Vaccine Maker Arrested by Police
  • 7/24/2018CNDA Solicits Comments on Linked Evaluation and Approval of APIs, Exci...
  • 7/24/2018SCMP: China's Vaccination System Has Been Crippled by Corruption, Weak...
  • 7/24/2018FT: Chinese Medical Tourism Exacerbates Shortage of HPV Vaccine
  • 7/17/2018China Embraces Another Vaccine Scandal
  • 7/10/2018Ping An Reportedly to Make Rival Offer for China Biologic
  • 7/4/2018Predicine and Kintor Pharma Collaborate on Precision Oncology Therapeu...
  • 6/25/2018Upcoming Event: World Congress on Virology 2018
  • 6/25/2018Upcoming Event: GUT Health Congress Asia 2018
  • 6/25/2018Upcoming Event: 5th World Congress on Epigenetics and Chromosome
  • 6/25/2018Upcoming Event: 7th International Conference on Neurology and Neuromus...
  • 6/22/2018Pacira Pharma and Nuance Biotech Announce License Agreement for EXPARE...
  • 6/20/2018Cipla Reportedly in Talks with Desano for A Majority-owned Chinese JV
  • 6/20/2018Pacira and Nuance Bio Announce License Agreement for Exparel in China
  • 6/19/2018CITIC Capital Proposes To Acquire China Biologic for $3.65B
  • 6/15/2018China's Vaccine Tourists Drain Hong Kong's Supply of Cancer Drug
  • 6/12/2018China Approves 4-Strain Flu Vaccine for 2018
  • 6/6/2018Hua Medicine Becomes Second Firm to Seek Hong Kong IPO under New Rules
  • 6/6/2018CDE Solicits Feedbacks on Draft Dossier Requirements for Registration ...
  • Page:22/68 Total number of articles:2026: [First][<<] [20] [21] [22] [23] [24] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group